Ratios Uncovered: Breaking Down Veracyte Inc (VCYT)’s Trailing Twelve Months Metrics

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

The price of Veracyte Inc (NASDAQ: VCYT) closed at $32.96 in the last session, down -3.37% from day before closing price of $34.11. In other words, the price has decreased by -$3.37 from its previous closing price. On the day, 1.55 million shares were traded.

Ratios:

We take a closer look at VCYT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.26. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.73. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on December 05, 2024, Downgraded its rating to Neutral and sets its target price to $37 from $38 previously.

On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.

On October 16, 2024, UBS started tracking the stock assigning a Buy rating and target price of $43.UBS initiated its Buy rating on October 16, 2024, with a $43 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when ANN MCGUIRE bought 1,142 shares for $33.56 per share.

MARC STAPLEY bought 52,697 shares of VCYT for $1,768,511 on Mar 04 ’25. On Mar 04 ’25, another insider, PHILLIP FEBBO, who serves as the Officer of the company, bought 8,037 shares for $33.56 each.

Valuation Measures:

As of this moment, Veracyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 107.54, and their Forward P/E ratio for the next fiscal year is 46.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.01. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.76 while its Price-to-Book (P/B) ratio in mrq is 2.18.

Stock Price History:

Over the past 52 weeks, VCYT has reached a high of $47.32, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is -19.38%, while the 200-Day Moving Average is calculated to be -0.04%.

Shares Statistics:

A total of 77.77M shares are outstanding, with a floating share count of 77.01M. Insiders hold about 1.20% of the company’s shares, while institutions hold 102.71% stake in the company.

Most Popular